Office of the Director, National Institutes of Health; Amended Notice of Meeting, 48759 [E9-23032]

Download as PDF Federal Register / Vol. 74, No. 184 / Thursday, September 24, 2009 / Notices Dated: September 17, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–23126 Filed 9–23–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the NIH Scientific Review Board, September 24, 2009, 8 a.m. to 3 p.m., National Institutes of Health, Building 60, Chapel and Lecture Hall, 9000 Rockville Pike, Bethesda, MD 20892 which was published in the Federal Register on September 14, 2009, 74 FR 46998. The notice is being amended to cancel the September 24, 2009, Deliberating Organizational Changes and Effectiveness Working Group forum. Please see the Scientific Management Review Board Web site for the schedule of upcoming meetings at: https:// smrb.od.nih.qov. For further information contact Dr. Lyric Jorgenson, Office of Science Policy, Office of the Director, National Institutes of Health, Building 1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892. Dated: September 16, 2009. Amy Patterson, Director, Office of Biotechnology Activities. [FR Doc. E9–23032 Filed 9–23–09; 8:45 am] would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences Integrated Review Group; Cellular Aspects of Diabetes and Obesity Study Section. Date: October 5–6, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Ann A. Jerkins, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6154, MSC 7892, Bethesda, MD 20892, 301–435– 4514, jerkinsa@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 16, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–23031 Filed 9–23–09; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health srobinson on DSKHWCL6B1PROD with NOTICES Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which VerDate Nov<24>2008 16:27 Sep 23, 2009 Jkt 217001 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Michael Micklin, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3136, MSC 7759, Bethesda, MD 20892, (301) 435– 1258, micklinm@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 16, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–23028 Filed 9–23–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Risk Communication Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES 48759 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel. Member Conflict: Interventions for Substance Abuse. Date: September 23, 2009. Time: 2 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Risk Communication Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on November 12, 2009, from 8 a.m. to 5 p.m. and November 13, 2009, from 8 a.m. to 2 p.m. Location: The Hilton Hotel, 8727 Colesville Rd., Silver Spring, MD 20910. Contact Person: Lee L. Zwanziger, Office of the Commissioner, Office of Policy, Planning and Preparedness, Office of Planning, Food and Drug Administration, 5600 Fishers Lane, rm. 14–90, Rockville, MD 20857, 301–827– 2895, FAX: 301–827–4050, e-mail: RCAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1–800–741– 8138 (301–443–0572 in the Washington, DC area), code 8732112560. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s Web site and call the E:\FR\FM\24SEN1.SGM 24SEN1

Agencies

[Federal Register Volume 74, Number 184 (Thursday, September 24, 2009)]
[Notices]
[Page 48759]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-23032]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the NIH 
Scientific Review Board, September 24, 2009, 8 a.m. to 3 p.m., National 
Institutes of Health, Building 60, Chapel and Lecture Hall, 9000 
Rockville Pike, Bethesda, MD 20892 which was published in the Federal 
Register on September 14, 2009, 74 FR 46998.
    The notice is being amended to cancel the September 24, 2009, 
Deliberating Organizational Changes and Effectiveness Working Group 
forum. Please see the Scientific Management Review Board Web site for 
the schedule of upcoming meetings at: https://smrb.od.nih.qov. For 
further information contact Dr. Lyric Jorgenson, Office of Science 
Policy, Office of the Director, National Institutes of Health, Building 
1, Room 218, MSC 0166, 9000 Rockville Pike, Bethesda, MD 20892.

    Dated: September 16, 2009.
Amy Patterson,
Director, Office of Biotechnology Activities.
[FR Doc. E9-23032 Filed 9-23-09; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.